Cara Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARA THERAP, and when can generic versions of CARA THERAP drugs launch?
CARA THERAP has one approved drug.
There are twelve US patents protecting CARA THERAP drugs.
There are forty-five patent family members on CARA THERAP drugs in twenty-five countries and twelve supplementary protection certificates in eleven countries.
Drugs and US Patents for Cara Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 9,334,305 | ⤷ Sign Up | ⤷ Sign Up | ||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 10,138,270 | ⤷ Sign Up | ⤷ Sign Up | ||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 7,727,963 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 10,017,536 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Cara Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Russian Federation | 2500685 | ⤷ Sign Up |
Japan | 2013241447 | ⤷ Sign Up |
European Patent Office | 2079756 | ⤷ Sign Up |
Hong Kong | 1130814 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cara Therap Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2064228 | 2022C/546 | Belgium | ⤷ Sign Up | PRODUCT NAME: DIFELIKEFALINE SOUS TOUTES LES FORMES COUVERTES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/22/1643 20220427 |
2064228 | CA 2022 00045 | Denmark | ⤷ Sign Up | PRODUCT NAME: DIFELIKEFALIN IN ALL FORMS COVERED BY THE BASIC PATENT; REG. NO/DATE: EU/1/22/1643 20220427 |
2064228 | 22C1054 | France | ⤷ Sign Up | PRODUCT NAME: DIFELIKEFALINE DANS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; REGISTRATION NO/DATE: EU/1/22/1643 20220427 |
2064228 | PA2022522 | Lithuania | ⤷ Sign Up | PRODUCT NAME: DIFELIKEFALINAS, BET KOKIA FORMA, KURIAI TAIKOMA PAGRINDINIO PATENTO APSAUGA ; REGISTRATION NO/DATE: EU/1/22/1643 20220425 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.